S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
NASDAQ:ICCM

IceCure Medical (ICCM) Stock Forecast, Price & News

$0.61
-0.05 (-7.57%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.61
$0.67
50-Day Range
$0.58
$1.23
52-Week Range
$0.52
$4.73
Volume
351,283 shs
Average Volume
218,001 shs
Market Capitalization
$27.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.33

IceCure Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
446.2% Upside
$3.33 Price Target
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.30mentions of IceCure Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.36) to ($0.39) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Medical Sector

842nd out of 963 stocks

Surgical & Medical Instruments Industry

86th out of 97 stocks


ICCM stock logo

About IceCure Medical (NASDAQ:ICCM) Stock

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

ICCM Price History

ICCM Stock News Headlines

His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Icecure Medical (ICCM) Receives a Buy from H.C. Wainwright
Expert Ratings for Icecure Medical
H.C. Wainwright Reaffirms Their Buy Rating on Icecure Medical (ICCM)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Icecure Medical (ICCM) Receives a Buy from Maxim Group
H.C. Wainwright Sticks to Their Buy Rating for Icecure Medical (ICCM)
What 5 Analyst Ratings Have To Say About Icecure Medical
IceCure Medical (NASDAQ: ICCM)
Maxim Group Sticks to Their Buy Rating for Icecure Medical (ICCM)
H.C. Wainwright Sticks to Its Buy Rating for Icecure Medical (ICCM)
See More Headlines
Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

ICCM Company Calendar

Last Earnings
8/14/2023
Today
9/24/2023
Next Earnings (Estimated)
12/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ICCM
Employees
65
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.33
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+446.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-16,980,000.00
Net Margins
-486.55%
Pretax Margin
-550.34%

Debt

Sales & Book Value

Annual Sales
$3.09 million
Book Value
$0.56 per share

Miscellaneous

Free Float
44,510,000
Market Cap
$27.84 million
Optionable
Not Optionable
Beta
0.11
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Eyal Shamir (Age 62)
    CEO & Director
    Comp: $467.32k
  • Mr. Ronen Tsimerman CPA (Age 54)
    CFO & COO
    Comp: $331.8k
  • Ms. Tlalit Bussi Tel-Tzure (Age 52)
    VP of Bus. Devel. & Global Marketing
    Comp: $279.34k
  • Ms. Merav Nir Dotan (Age 54)
    VP of HR
    Comp: $197.96k
  • Ms. Galit Malik (Age 50)
    VP of Operations & Service













ICCM Stock - Frequently Asked Questions

Should I buy or sell IceCure Medical stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICCM shares.
View ICCM analyst ratings
or view top-rated stocks.

What is IceCure Medical's stock price forecast for 2023?

3 Wall Street research analysts have issued twelve-month target prices for IceCure Medical's stock. Their ICCM share price forecasts range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.33 in the next twelve months. This suggests a possible upside of 446.2% from the stock's current price.
View analysts price targets for ICCM
or view top-rated stocks among Wall Street analysts.

How have ICCM shares performed in 2023?

IceCure Medical's stock was trading at $1.55 at the start of the year. Since then, ICCM stock has decreased by 60.6% and is now trading at $0.6103.
View the best growth stocks for 2023 here
.

Are investors shorting IceCure Medical?

IceCure Medical saw a increase in short interest in August. As of August 31st, there was short interest totaling 79,800 shares, an increase of 128.0% from the August 15th total of 35,000 shares. Based on an average daily trading volume, of 139,700 shares, the short-interest ratio is presently 0.6 days. Currently, 0.4% of the company's shares are sold short.
View IceCure Medical's Short Interest
.

When is IceCure Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, December 4th 2023.
View our ICCM earnings forecast
.

How were IceCure Medical's earnings last quarter?

IceCure Medical Ltd (NASDAQ:ICCM) posted its quarterly earnings data on Monday, August, 14th. The company reported ($0.09) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.09). The business had revenue of $0.94 million for the quarter, compared to analysts' expectations of $0.80 million. IceCure Medical had a negative trailing twelve-month return on equity of 77.22% and a negative net margin of 486.55%.

What is IceCure Medical's stock symbol?

IceCure Medical trades on the NASDAQ under the ticker symbol "ICCM."

How do I buy shares of IceCure Medical?

Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IceCure Medical's stock price today?

One share of ICCM stock can currently be purchased for approximately $0.61.

How much money does IceCure Medical make?

IceCure Medical (NASDAQ:ICCM) has a market capitalization of $27.84 million and generates $3.09 million in revenue each year. The company earns $-16,980,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis.

How can I contact IceCure Medical?

The official website for the company is www.icecure-medical.com. The company can be reached via phone at 972-4623-0333, via email at jeremy@lifesciadvisors.com, or via fax at 972-4623-0222.

This page (NASDAQ:ICCM) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -